{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:00:02Z","timestamp":1787061602757,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012964","name":"Enseignement Sup\u00e9rieur et de la Recherche Scientifique","doi-asserted-by":"publisher","award":["ORF-2026-17"],"award-info":[{"award-number":["ORF-2026-17"]}],"id":[{"id":"10.13039\/100012964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.humimm.2025.111652","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T22:54:26Z","timestamp":1767308066000},"page":"111652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["HLA-E gene polymorphism and expression in colorectal cancer patients"],"prefix":"10.1016","volume":"87","author":[{"given":"Sabrine","family":"Dhouioui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Boujelbene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Hasni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houyem","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hager","family":"Bourog\u00e2a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maroua","family":"Jalouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Mokrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rym","family":"Mchiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel Halim","family":"Harrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Zemni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4660-3870","authenticated-orcid":false,"given":"Vera","family":"Rebmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1170-4957","authenticated-orcid":false,"given":"Ines","family":"Zidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.humimm.2025.111652_b0005","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.humimm.2025.111652_b0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.humimm.2025.111652_b0015","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/sj.bjc.6603628","article-title":"Gender differences in colorectal cancer: implications for age at initiation of screening","volume":"96","author":"Brenner","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.humimm.2025.111652_b0020","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1186\/s12885-018-4786-7","article-title":"A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK","volume":"18","author":"White","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humimm.2025.111652_b0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0065-230X(01)83005-0","article-title":"MHC antigens and tumor escape from immune surveillance","volume":"83","author":"Garrido","year":"2001","journal-title":"Adv. Cancer Res."},{"issue":"9","key":"10.1016\/j.humimm.2025.111652_b0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.humimm.2016.03.001","article-title":"HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases","volume":"77","author":"Swets","year":"2016","journal-title":"Hum. Immunol."},{"issue":"28","key":"10.1016\/j.humimm.2025.111652_b0035","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.2174\/138161209789105207","article-title":"HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells","volume":"15","author":"Pietra","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.humimm.2025.111652_b0040","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2695396","article-title":"Characteristics of HLA-E Restricted T-Cell responses and their Role in Infectious Diseases","volume":"2016","author":"Joosten","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"5","key":"10.1016\/j.humimm.2025.111652_b0045","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.4049\/jimmunol.177.5.3100","article-title":"Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells","volume":"177","author":"Derr\u00e9","year":"2006","journal-title":"J. Immunol."},{"issue":"18","key":"10.1016\/j.humimm.2025.111652_b0050","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1073\/pnas.0802736105","article-title":"Structural basis for NKG2A\/CD94 recognition of HLA-E","volume":"105","author":"Kaiser","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.humimm.2025.111652_b0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4049\/jimmunol.162.1.305","article-title":"Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94\/NKG2A and NK cells","volume":"162","author":"Brooks","year":"1999","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2025.111652_b0060","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W","article-title":"HLA-E-bound peptides influence recognition by inhibitory and triggering CD94\/NKG2 receptors: preferential response to an HLA-G-derived nonamer","volume":"28","author":"Llano","year":"1998","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.humimm.2025.111652_b0065","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41590-023-01523-z","article-title":"HLA class I signal peptide polymorphism determines the level of CD94\/NKG2-HLA-E-mediated regulation of effector cell responses","volume":"24","author":"Lin","year":"2023","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2025.111652_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2024.101560","article-title":"Is HLA-E with its receptors an immune checkpoint or an antigenic determinant in allo-HCT?","volume":"37","author":"Rohn","year":"2024","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"3","key":"10.1016\/j.humimm.2025.111652_b0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/molehr\/8.3.255","article-title":"Th1- and Th2-like cytokine production by first trimester decidual large granular lymphocytes is influenced by HLA-G and HLA-E","volume":"8","author":"Rieger","year":"2002","journal-title":"Mol. Hum. Reprod."},{"issue":"5","key":"10.1016\/j.humimm.2025.111652_b0080","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1055\/s-2002-34102","article-title":"Expression of the molecules HLA-G and HLA-E modulates cytokine production of monocyte generated dendritic cells","volume":"124","author":"Steck","year":"2002","journal-title":"Zentralbl. Gynakol."},{"issue":"5","key":"10.1016\/j.humimm.2025.111652_b0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1399-0039.2008.01138.x","article-title":"The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity","volume":"72","author":"Sullivan","year":"2008","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.humimm.2025.111652_b0090","first-page":"2279","article-title":"Human leukocyte antigen (HLA)-E and HLA-F expression in gastric cancer","volume":"35","author":"Ishigami","year":"2015","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.humimm.2025.111652_b0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cellimm.2014.10.003","article-title":"Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients","volume":"293","author":"Guo","year":"2015","journal-title":"Cell. Immunol."},{"issue":"41","key":"10.1016\/j.humimm.2025.111652_b0100","doi-asserted-by":"crossref","first-page":"67360","DOI":"10.18632\/oncotarget.11744","article-title":"HLA-E expression and its clinical relevance in human renal cell carcinoma","volume":"7","author":"Seliger","year":"2016","journal-title":"Oncotarget"},{"issue":"26","key":"10.1016\/j.humimm.2025.111652_b0105","doi-asserted-by":"crossref","first-page":"10656","DOI":"10.1073\/pnas.1100354108","article-title":"HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes","volume":"108","author":"Gooden","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.humimm.2025.111652_b0110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.humimm.2020.12.008","article-title":"HLA-E typing of more than 2.5 million potential hematopoietic stem cell donors: Methods and population-specific allele frequencies","volume":"82","author":"Sauter","year":"2021","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2025.111652_b0115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/tan.14195","article-title":"HLA-E diversity unfolded: Identification and characterization of 170 novel HLA-E alleles","volume":"97","author":"Paech","year":"2021","journal-title":"Hla"},{"issue":"3","key":"10.1016\/j.humimm.2025.111652_b0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/tan.12767","article-title":"HLA-E polymorphism and soluble HLA-E plasma levels in chronic hepatitis B patients","volume":"87","author":"Zidi","year":"2016","journal-title":"Hla"},{"key":"10.1016\/j.humimm.2025.111652_b0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-61779-842-9_8","article-title":"Molecular typing of HLA-E","volume":"882","author":"Lauterbach","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.humimm.2025.111652_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021118","article-title":"Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer","volume":"6","author":"Allard","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2025.111652_b0135","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/346714","article-title":"HLA-E: Presentation of a broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome","volume":"2015","author":"Kraemer","year":"2015","journal-title":"Stem Cells Int."},{"issue":"4","key":"10.1016\/j.humimm.2025.111652_b0140","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.4049\/jimmunol.1001081","article-title":"HLA-G expression in human embryonic stem cells and preimplantation embryos","volume":"186","author":"Verloes","year":"2011","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2025.111652_b0145","article-title":"The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients","volume":"10","author":"Veit","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2025.111652_b0150","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3389\/fimmu.2020.02046","article-title":"Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 positive and ILT-2 negative CD8 T Cells Complementary","volume":"11","author":"Schwich","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2025.111652_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6829283","article-title":"The Pathophysiological Impact of HLA Class Ia and HLA-G Expression and Regulatory T Cells in Malignant Melanoma: a Review","volume":"2016","author":"Johansen","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.humimm.2025.111652_b0160","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2119\/molmed.2015.00083","article-title":"Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy","volume":"21","author":"Lin","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.humimm.2025.111652_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104588","article-title":"Association of HLA diversity with the risk of 25 cancers in the UK Biobank","volume":"92","author":"Wang","year":"2023","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.humimm.2025.111652_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135512","article-title":"HLA Allele E*01:01 is Associated with a Reduced risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01\/*02","volume":"10","author":"Mart\u00edn","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.humimm.2025.111652_b0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10428194.2018.1474521","article-title":"Clinical significance of HLA-E genotype and surface\/soluble expression levels between healthy individuals and patients with acute leukemia","volume":"60","author":"Xu","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.humimm.2025.111652_b0180","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/cas.12641","article-title":"Human leukocyte antigen-E alleles and expression in patients with serous ovarian cancer","volume":"106","author":"Zheng","year":"2015","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.humimm.2025.111652_b0185","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1399-0039.2004.00311.x","article-title":"HLA-E polymorphism in patients with nasopharyngeal carcinoma","volume":"64","author":"Hirankarn","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2025.111652_b0190","unstructured":"Y. Zhou, Z. Wu, Y.-h. Tang, and T. Jia, [HLA-E gene polymorphisms and plasma soluble HLA-E levels and their relationship with genetic susceptibility to breast cancer]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2015. 31 4: p. 524-527."},{"issue":"8","key":"10.1016\/j.humimm.2025.111652_b0195","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/dna.2010.1140","article-title":"Lack of association between human leukocyte antigen-E alleles and nasopharyngeal carcinoma in Tunisians","volume":"30","author":"Hassen","year":"2011","journal-title":"DNA Cell Biol."},{"issue":"5","key":"10.1016\/j.humimm.2025.111652_b0200","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/08820139.2019.1569043","article-title":"The Impact of HLA-G 3'UTR Polymorphisms in Breast Cancer in a Tunisian Population","volume":"48","author":"Ouni","year":"2019","journal-title":"Immunol. Invest."},{"issue":"1","key":"10.1016\/j.humimm.2025.111652_b0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdermsci.2005.07.003","article-title":"Lack of association between HLA-E polymorphism and primary cutaneous melanoma in spanish patients","volume":"40","author":"Moya-Quiles","year":"2005","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.humimm.2025.111652_b0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/tan.12159","article-title":"Lack of association between HLA-E polymorphisms and transitional cell carcinoma of the bladder","volume":"82","author":"Veiga-Castelli","year":"2013","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.humimm.2025.111652_b0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.humimm.2023.02.002","article-title":"HLA-E*01:01+HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03+HLA-E*01:03 genotype is associated with more severe disease","volume":"84","author":"Hosseini","year":"2023","journal-title":"Hum. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2025.111652_b0220","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0198-8859(03)00093-4","article-title":"Soluble nonclassical HLA generated by the metalloproteinase pathway","volume":"64","author":"Dong","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2025.111652_b0225","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/956878","article-title":"Plasma levels of soluble HLA-E and HLA-F at diagnosis may predict overall survival of neuroblastoma patients","volume":"2013","author":"Morandi","year":"2013","journal-title":"Biomed Res. Int."},{"issue":"23","key":"10.1016\/j.humimm.2025.111652_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316699","article-title":"HLA-E and its Soluble Form as Indicators of a Sex-specific Immune Response in patients with Oral Squamous Cell Carcinoma","volume":"24","author":"Radermacher","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.humimm.2025.111652_b0235","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.4049\/jimmunol.1002629","article-title":"HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients","volume":"185","author":"de Kruijf","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2025.111652_b0240","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1479-5876-9-184","article-title":"High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis","volume":"9","author":"Benevolo","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.humimm.2025.111652_b0245","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1479-5876-10-184","article-title":"HLA-E expression in cervical adenocarcinomas: association with improved long-term survival","volume":"10","author":"Spaans","year":"2012","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.humimm.2025.111652_b0250","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211047278","article-title":"Lesion human leukocyte antigen-E is associated with favourable prognosis for patients with oesophageal squamous cell carcinoma","volume":"49","author":"Xu","year":"2021","journal-title":"J. Int. Med. Res."},{"issue":"7","key":"10.1016\/j.humimm.2025.111652_b0255","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1074\/jbc.M208268200","article-title":"HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities","volume":"278","author":"Strong","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.humimm.2025.111652_b0260","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/cncr.30427","article-title":"HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia","volume":"123","author":"Wagner","year":"2017","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.humimm.2025.111652_b0265","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1007\/s00432-022-04532-x","article-title":"Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines","volume":"149","author":"Lee","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111652_b0270","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12032-013-0482-2","article-title":"Impact of HLA-E gene polymorphism on HLA-E expression in tumor cells and prognosis in patients with stage III colorectal cancer","volume":"30","author":"Zhen","year":"2013","journal-title":"Med. Oncol."},{"key":"10.1016\/j.humimm.2025.111652_b0275","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2025.111652_b0280","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/bmt.2008.380","article-title":"HLA-E upregulation on IFN-gamma-activated AML blasts impairs CD94\/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT","volume":"43","author":"Nguyen","year":"2009","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.humimm.2025.111652_b0285","first-page":"633","article-title":"Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer","volume":"32","author":"Levy","year":"2008","journal-title":"Int. J. Oncol."},{"issue":"14","key":"10.1016\/j.humimm.2025.111652_b0290","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1128\/MCB.24.14.6194-6204.2004","article-title":"A GATA factor mediates cell type-restricted induction of HLA-E gene transcription by gamma interferon","volume":"24","author":"Barrett","year":"2004","journal-title":"Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.humimm.2025.111652_b0295","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00262-004-0654-1","article-title":"Sustained low-level expression of interferon-gamma promotes tumor development: potential insights in tumor prevention and tumor immunotherapy","volume":"54","author":"He","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"issue":"14","key":"10.1016\/j.humimm.2025.111652_b0300","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1158\/0008-5472.CAN-19-0596","article-title":"Low-Dose IFN\u03b3 Induces Tumor Cell Stemness in Tumor Microenvironment of Non-Small Cell Lung Cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.humimm.2025.111652_b0305","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1535-7163.MCT-11-0758","article-title":"Selective targeting of interferon \u03b3 to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth","volume":"11","author":"Bansal","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.humimm.2025.111652_b0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/jir.2014.0132","article-title":"Deficiency of interferon-gamma or its receptor promotes colorectal cancer development","volume":"35","author":"Wang","year":"2015","journal-title":"J. Interferon Cytokine Res."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925004240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925004240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:23:13Z","timestamp":1781511793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885925004240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0198885925004240"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111652","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-E gene polymorphism and expression in colorectal cancer patients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111652"}}